OC-301 (Oncocross)

N/A

Report date: 2025/03/19 11:43:24

NME

Base Information

Drug NameOC-301 (Oncocross)

Drug Alias NameOC-301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors

TargetsPoly (ADP-Ribose) polymerase 1

Therapy Area/IndicationsHealthy AgingAlopecia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOncocross Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHealthy AgingAlopecia

Inactive IndicationsN/A

ATC CodeN/A